J. Khan-Boluki

Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study

T E Romer, Paul Saenger, F Péter et al. · Hormone Research in Paediatrics · 2009 · 45 citations

Medicine, Endocrinology, Pediatrics +13

The effect of anti-L-selectin (aselizumab) in multiple traumatized patients—Results of a phase II clinical trial*

Andreas Seekamp, Martijn van Griensven, Erwin Dhondt et al. · Critical Care Medicine · 2004 · 34 citations

Medicine, Immunology, Pharmacotherapy +14

Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study

Juan Pedro López‐Siguero, Victoria Borrás Pérez, Sigrid Balser et al. · Advances in Therapy · 2011 · 26 citations

Medicine, Endocrinology, Pediatrics +11

Measuring the Efficacy of Psychopharmacological Treatment of Psychomotors Restlessness in Dementia: Clinical Evaluation of Tiapride

Hans Gutzmann, Klaus-Peter Kühl, S. Kanowski et al. · Pharmacopsychiatry · 1997 · 20 citations

Medicine, Pharmacotherapy, Psychiatry +17

One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Hans‐Peter Schwarz, Dorota Birkholz-Walerzak, Mieczysław Szalecki et al. · Biologics in Therapy · 2014 · 18 citations · Full text

Medicine, Endocrinology, Pediatrics +17